Division of Global Migration Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Zoonoses Public Health. 2024 Sep;71(6):620-628. doi: 10.1111/zph.13122. Epub 2024 Mar 6.
Dog-mediated rabies virus variant (DMRVV), a zoonotic pathogen that causes a deadly disease in animals and humans, is present in more than 100 countries worldwide but has been eliminated from the United States since 2007. In the United States, the U.S. Centers for Disease Control and Prevention has recorded four instances of rabies in dogs imported from DMRVV-enzootic countries since 2015. However, it remains uncertain whether the incidence of DMRVV among imported dogs from these countries significantly surpasses that of domestically acquired variants among domestic U.S. dogs.
This evaluation aimed to estimate the number of dogs imported from DMRVV-enzootic countries and compare the risk of rabies between imported dogs and the U.S. domestic dog population.
Data from the CDC's dog import permit system (implemented during 2021 under a temporary suspension of dog importation from DMRVV-enzootic countries) and U.S. Customs and Border Protection's Automated Commercial Environment system, each of which records a segment of dogs entering the U.S. from DMRVV-enzootic countries, was analysed. Additionally, we estimated the incidence rate of rabies in dogs imported from DMRVV-enzootic countries and compared it to the incidence rate within the general U.S. dog population, due to domestically acquired rabies variants, over the eight-year period (2015-2022).
An estimated 72,589 (range, 62,660-86,258) dogs were imported into the United States annually between 2015 and 2022 from DMRVV-enzootic countries. The estimated incidence rate of rabies was 16 times higher (range, 13.2-19.4) in dogs imported from DMRVV-enzootic countries than that estimated for domestically acquired rabies in the general U.S. dog population.
Preventing human exposure to dogs with DMRVV is a public health priority. The higher risk of rabies in dogs imported from DMRVV-enzootic countries supports the need for importation requirements aimed at preventing the reintroduction of DMRVV into the United States.
犬介导的狂犬病病毒变异株(DMRVV)是一种人畜共患病原体,可导致动物和人类致命疾病,目前在全球 100 多个国家流行,但自 2007 年以来已从美国消除。在美国,美国疾病控制与预防中心自 2015 年以来已记录了 4 例从 DMRVV 流行国家进口的狗感染狂犬病病例。然而,目前尚不确定这些国家进口犬的 DMRVV 发病率是否明显高于美国国内犬的国内获得性变异株发病率。
本评估旨在估计从 DMRVV 流行国家进口的犬数量,并比较进口犬与美国国内犬群之间狂犬病的风险。
分析了美国疾病控制与预防中心的犬进口许可证系统(在 DMRVV 流行国家的犬进口临时暂停期间于 2021 年实施)和美国海关与边境保护局的自动商业环境系统的数据,这两个系统都记录了从 DMRVV 流行国家进入美国的犬的一部分。此外,我们还估算了从 DMRVV 流行国家进口的犬的狂犬病发病率,并与 2015 年至 2022 年期间因国内获得性狂犬病变异株而在美国一般犬群中的发病率进行了比较。
2015 年至 2022 年期间,每年从 DMRVV 流行国家进口到美国的犬数量估计为 72589 只(范围为 62660-86258 只)。从 DMRVV 流行国家进口的犬的狂犬病估计发病率比美国一般犬群中因国内获得性狂犬病而估计的发病率高 16 倍(范围为 13.2-19.4)。
防止人类接触携带 DMRVV 的犬是公共卫生的重点。从 DMRVV 流行国家进口的犬狂犬病风险较高,支持了为防止 DMRVV 重新引入美国而制定进口要求的必要性。